81 related articles for article (PubMed ID: 22446113)
1. Increased serum level of epidermal growth factor receptor in liver cancer patients and its association with exposure to arsenic.
Sung TI; Wang YJ; Chen CY; Hung TL; Guo HR
Sci Total Environ; 2012 May; 424():74-8. PubMed ID: 22446113
[TBL] [Abstract][Full Text] [Related]
2. Elevated serum epidermal growth factor receptor level is correlated with lymph node metastasis in lung cancer.
Sasaki H; Yukiue H; Mizuno K; Sekimura A; Konishi A; Yano M; Kaji M; Kiriyama M; Fukai I; Yamakawa Y; Fujii Y
Int J Clin Oncol; 2003 Apr; 8(2):79-82. PubMed ID: 12720099
[TBL] [Abstract][Full Text] [Related]
3. Detection of epidermal growth factor receptor in the serum of gastric carcinoma patients.
Choi JH; Oh JY; Ryu SK; Kim SJ; Lee NY; Kim YS; Yi SY; Shim KS; Han WS
Cancer; 1997 May; 79(10):1879-83. PubMed ID: 9149012
[TBL] [Abstract][Full Text] [Related]
4. Circulating transforming growth factor-β and epidermal growth factor receptor as related to virus infection in liver carcinogenesis.
Divella R; Daniele A; Gadaleta C; Tufaro A; Venneri MT; Paradiso A; Quaranta M
Anticancer Res; 2012 Jan; 32(1):141-5. PubMed ID: 22213299
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of serum epidermal growth factor receptor level in patients with non-small cell lung cancer.
Ciledağ A; Kaya A; Yetkin O; Poyraz B; Savaş I; Numanoğlu N; Savaş H
Tuberk Toraks; 2008; 56(4):390-5. PubMed ID: 19123074
[TBL] [Abstract][Full Text] [Related]
6. Detection of epidermal growth factor receptor in the serum of patients with cervical carcinoma.
Oh MJ; Choi JH; Kim IH; Lee YH; Huh JY; Park YK; Lee KW; Chough SY; Joo KS; Ku BS; Saw HS
Clin Cancer Res; 2000 Dec; 6(12):4760-3. PubMed ID: 11156231
[TBL] [Abstract][Full Text] [Related]
7. Mutant p53 protein in the serum of patients with colorectal cancer: Correlation with the level of carcinoembryonic antigen and serum epidermal growth factor receptor.
Abdel-Aziz MM; Lotfy M; El-Kady IM; Abozaid M
Cancer Detect Prev; 2009; 32(4):329-35. PubMed ID: 16632243
[TBL] [Abstract][Full Text] [Related]
8. Serum EGFR and serum HER-2/neu are useful predictive and prognostic markers in metastatic breast cancer patients treated with metronomic chemotherapy.
Sandri MT; Johansson HA; Zorzino L; Salvatici M; Passerini R; Maisonneuve P; Rocca A; Peruzzotti G; Colleoni M
Cancer; 2007 Aug; 110(3):509-17. PubMed ID: 17559147
[TBL] [Abstract][Full Text] [Related]
9. Does arsenic exposure increase the risk for liver cancer?
Chiu HF; Ho SC; Wang LY; Wu TN; Yang CY
J Toxicol Environ Health A; 2004 Oct; 67(19):1491-500. PubMed ID: 15371225
[TBL] [Abstract][Full Text] [Related]
10. Correlation of clinicopathological parameters with HGF, c-Met, EGFR, and IGF-1R expression in uveal melanoma.
Topcu-Yilmaz P; Kiratli H; Saglam A; Söylemezoglu F; Hascelik G
Melanoma Res; 2010 Apr; 20(2):126-32. PubMed ID: 20061986
[TBL] [Abstract][Full Text] [Related]
11. Ingested arsenic, characteristics of well water consumption and risk of different histological types of lung cancer in northeastern Taiwan.
Chen CL; Chiou HY; Hsu LI; Hsueh YM; Wu MM; Chen CJ
Environ Res; 2010 Jul; 110(5):455-62. PubMed ID: 19735913
[TBL] [Abstract][Full Text] [Related]
12. Arsenic levels in drinking water and mortality of liver cancer in Taiwan.
Lin HJ; Sung TI; Chen CY; Guo HR
J Hazard Mater; 2013 Nov; 262():1132-8. PubMed ID: 23352725
[TBL] [Abstract][Full Text] [Related]
13. Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer.
Baron AT; Lafky JM; Boardman CH; Balasubramaniam S; Suman VJ; Podratz KC; Maihle NJ
Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):129-37. PubMed ID: 10067810
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the prognostic value of soluble epidermal growth factor receptor plasma concentration in advanced non-small-cell lung cancer patients.
Jantus-Lewintre E; Sirera R; Cabrera A; Blasco A; Caballero C; Iranzo V; Rosell R; Camps C
Clin Lung Cancer; 2011 Sep; 12(5):320-7. PubMed ID: 21729651
[TBL] [Abstract][Full Text] [Related]
15. Hypertension incidence after tap-water implementation: a 13-year follow-up study in the arseniasis-endemic area of southwestern Taiwan.
Wang SL; Li WF; Chen CJ; Huang YL; Chen JW; Chang KH; Tsai LY; Chou KM
Sci Total Environ; 2011 Oct; 409(21):4528-35. PubMed ID: 21872294
[TBL] [Abstract][Full Text] [Related]
16. Risk of carotid atherosclerosis is associated with low serum paraoxonase (PON1) activity among arsenic exposed residents in Southwestern Taiwan.
Li WF; Sun CW; Cheng TJ; Chang KH; Chen CJ; Wang SL
Toxicol Appl Pharmacol; 2009 Apr; 236(2):246-53. PubMed ID: 19371607
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum epidermal growth factor receptor level in stage IV thymoma.
Sasaki H; Yukiue H; Sekimura A; Mizuno K; Konishi A; Yano M; Fukai I; Fujii Y
Surg Today; 2004; 34(5):477-9. PubMed ID: 15108095
[TBL] [Abstract][Full Text] [Related]
18. Increased urokinase-type plasminogen activator receptor and epidermal growth factor receptor in serum of patients with prostate cancer.
Milanese G; Dellabella M; Fazioli F; Pierpaoli E; Polito M; Siednius N; Montironi R; Blasi F; Muzzonigro G
J Urol; 2009 Mar; 181(3):1393-400. PubMed ID: 19157433
[TBL] [Abstract][Full Text] [Related]
19. Enzyme immunoassay of human epidermal growth factor receptor (hEGFR).
Kumar RR; Meenakshi A; Sivakumar N
Hum Antibodies; 2001; 10(3-4):143-7. PubMed ID: 11847425
[TBL] [Abstract][Full Text] [Related]
20. Serum epidermal growth factor receptor levels in patients with malignant melanoma.
Kanemura H; Fukushima S; Yamashita J; Jinnin M; Sakai K; Masuguchi S; Aoi J; Makino T; Inoue Y; Ihn H
Clin Exp Dermatol; 2013 Mar; 38(2):172-7. PubMed ID: 23397945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
